Genetic Architecture of Avoidant/Restrictive Food Intake Disorder (ARFID-GEN)
Sponsor: National Institute of Mental Health (NIMH)
Listed as NCT05605067, this observational or N/A phase trial focuses on ARFID and Eating Disorders and remains completed. Sponsored by National Institute of Mental Health (NIMH), it has been updated 6 times since 2023, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Nov 2024 — Present [monthly]
Completed
-
Sep 2024 — Nov 2024 [monthly]
Completed
Status: Recruiting → Completed
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Jul 2023 — Jul 2024 [monthly]
Recruiting
-
Feb 2023 — Jul 2023 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
▶ Show 1 earlier version
-
Dec 2022 — Feb 2023 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- National Institute of Mental Health (NIMH)
- Psychiatric Center Ballerup
- University of North Carolina, Chapel Hill
For direct contact, visit the study record on ClinicalTrials.gov .